Homosexual Behavior Fuels AIDS and STD Epidemic

Homosexual Behavior Fuels AIDS and STD Epidemic


Tuesday, July 02, 2013

Traditional Values Coalition, 139 C St. SE, Washington, DC 20003; 202-547-8570; www.traditionalvalues.org.

All graphics taken from AIDS.gov (http://aids.gov/hiv-aids-basics/hiv-aids-101/statistics/)

NOTE: This article contains somewhat graphic and potentially disturbing descriptions of homosexual acts and their consequences. It is not recommended for young or sensitive readers.

December, 2003 — The Centers for Disease Control (CDC) announced on November 26, 2003, that AIDS infections increased in 29 states in 2002 among Blacks, Latinos, and Homosexual and Bisexual men. The overall rate of increase was 5.1% over a four-year period between 1999-2002. Fifty-five percent of these infections are among Blacks; there was a 26% increase among Latinos; and a 17% increase among homosexuals and bisexuals. There was a 7% increase in AIDS infections among nonhomosexuals. These CDC statistics are published in the November 28 issue of Morbidity and Mortality Weekly Report (MMWR).

Dr. John Diggs, Jr., has recently published statistics on the serious health consequences of engaging on homosexual sodomy. His report, “The Health Risks of Gay Sex,” was published by the Corporate Resource Council.

Dr. Diggs notes that homosexual sodomy is an efficient transmitter of a whole range of STD’s including AIDS. He also points out that human physiology makes it clear that anal intercourse itself is an unhealthy practice that damages the body and can lead to serious health consequences—including anal cancer. “Unhealthy sexual behaviors occur among both heterosexuals and homosexuals. Yet the medical and social science evidence indicate that homosexual behavior is uniformly unhealthy,” observes Diggs.

The sexual activities engaged in by homosexuals inevitably lead to a whole range of viral and bacterial infections that can result in sterility, cancer, and death.

Sex among homosexual males typically includes: oral and anal sex; rimming (mouth-to-anus contact); fisting (insertion of the hand and arm into the rectum); golden showers (urination); insertion of objects such as bottles, flashlights, and even gerbils into the rectum; sadomasochism (beatings with whips, chains, etc.); and other practices. These various behaviors cause trauma to the rectum, contribute to the spread of AIDS; increase incidences of oral and anal cancer; and result in serious infections due to the ingestion of fecal matter.

One of the largest surveys ever conducted of homosexual sex practices was published by two homosexual researchers in 1979. In The Gay Report by Jay and Young, 37% of homosexuals interviewed indicated they had engaged in sadomasochistic activities; 23% had been involved in “water sports,” (urinating on the sex partner); 4% had been involved in defecation; 11% had been involved in giving enemas to their sex partners.

Dr. Gisela L.P. Macphail, a physician at the University of Calgary in Canada, described the serious health risks of homosexual behavior in a letter to the Calgary Board of Education in September, 1996. She is an epidemiologist and regularly treats AIDS patients. According to Dr. Macphail, “Any practice which facilitates direct or indirect oral-rectal contact will enable the spread of fecal and rectal microorganisms to the sexual partner. Thus anilingus (rimming), a common practice among homosexual men, allows direct spread of pathogens such as Giardia, Entamoeba histolytica, and Hepatitis A and of the typical STD organisms such as herpes simplex and gonorrhea.” She warned the Calgary school district against promoting homosexual behavior among school children because of the serious health risks.

In August, 1984, just three years after AIDS was diagnosed as a public health threat to homosexuals, columnist Patrick Buchanan and researcher Dr. J. Gordon Muir published an in-depth look at the “Gay” lifestyle and the diseases associated with it in The American Spectator. Writing in “Gay Times and Gay Diseases,” the authors described a series of serious diseases comprising the “Gay Bowel Syndrome.”

Those viruses, parasites, and bacteria resulting from homosexual sexual practices include: Amebiasis, a parasitic colon disease which causes dysentery and liver abscesses; Giardiasis, a parasite that causes diarrhea; Shigellosis, another bowel disease causing dysentery, Hepatitis A, a viral liver disease spread by fecal contamination.
According to Buchanan and Muir, San Francisco saw a four-to-ten-fold increase in gay bowel diseases beginning in 1977. As long ago as 1988, San Francisco had a venereal disease infection rate 22 times the national average.

Anal Cancer — Dr. Stephen E. Goldstone, the medical director of GayHealth.com says he has found that 68% of HIV-positive and 45% of HIVnegative homosexual males have abnormal or precancerous anal cells. A 1987 study, “Sexual Practices, Sexually Transmitted Diseases, and the Incidences of Anal Cancer” in the New England Journal of Medicine concluded that “homosexual behavior in men increases the risk of anal cancer: 21 of the 57 men with anal cancer (37%) reported that they were homosexual or bisexual, in contrast to only 1 in 64 controls.”

HIV from Oral Sex — In August, 2001, researchers at the University of California released the results of a preliminary study of the risk of getting HIV from oral sex. They claimed that homosexuals are at a zero to 2% risk of getting HIV from oral sex. But a study released earlier in 2001 indicated that oral sex is implicated in at least 8% of HIV infections. This earlier study was published in February by the CDC and the University of California at San Francisco.

HIV from Anal Intercourse — In the U.S., anal intercourse continues to be the primary transmission route of HIV infection for homosexuals. The CDC says there are 40,000 new infections each year and the rate of infection is climbing because many younger homosexuals are engaging in risky behaviors. Many have become complacent about the epidemic because of new drugs that control the progression of the disease. As a result, homosexuals are staying alive longer and infecting more individuals. As of 1998, 54% of all HIV infections were homosexuals. An estimated 1 million Americans have been infected with HIV since it was first discovered in the early 1980s. Worldwide, 21 million people have died; 450,000 Americans have died so far from HIV-related diseases.

Sexually Transmitted Diseases — A 1999 study published in the American Journal of Public Health indicated that homosexuals are five times as likely to have Hepatitis B as their heterosexual counterparts. A 1999 study in Sexually Transmitted Diseases indicated that 25% of homosexuals have rectal Gonorrhea and Gonorrhea of the throat is prevalent because of oral sex practices. The book, The Ins and Outs of Gay Sex: A Medical Handbook for Men states that more than 50% of homosexual males have the Human Papilloma Virus. Homosexuals are acquiring Syphilis in record numbers. The CDC released two reports on Syphilis in February, 2001. One report said that Syphilis rates had declined by 22% in the U.S. since 1997. The second indicated that Syphilis rates among homosexuals in Southern California had risen from 26% to 51% in one year. The report also noted that in Southern California alone, 60% of Syphilis-infected homosexuals were also HIV positive.

Tuberculosis — Homosexuals are at high risk for spreading Tuberculosis. In June-August 1998, the Baltimore Health Department tracked the spread of TB by four black transgendered homosexual prostitutes. They had infected 22 others with TB through their sexual activities. TB infection was also spread from Baltimore to New York City.
Homosexual behavior is unsafe and should not be promoted as a healthful or harmless lifestyle!

Dr. Diggs notes, “A compassionate response to requests for social approval and recognition of GLB [gay, lesbian, bisexual] relationships is not to assure gays and lesbians that homosexual relationships are just like heterosexual ones, but to point out the health risks of gay sex and promiscuity. Approving same-sex relationships is detrimental to employers, employees, and society in general.”

Homosexual sex leads to serious venereal diseases, anal and oral cancer, and death from HIV infection. This behavior must be discouraged—not promoted as an alternative lifestyle. Sodomy kills.

FDA Policy on Blood Donations from Homosexual Men

FDA Policy on Blood Donations from Homosexual Men


Tuesday, July 02, 2013

The following is from the website of the Center for Disease Control (CDC). The page has since been updated, but they still hold to a policy of lifetime deferral for men who have sex with men (MSM). Their current policy can be viewed at http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/QuestionsaboutBlood/ucm108186.htm The graphics were taken from the CDC fact sheet on new HIV infections in the US. It can be viewed at http://www.cdc.gov/nchhstp/newsroom/docs/2012/HIV-Infections-2007-2010.pdf

What is FDA’s policy on blood donations from men who have sex with other men (MSM)?

Men who have had sex with other men, at any time since 1977 (the beginning of the AIDS epidemic in the United States) are currently deferred as blood donors. This is because MSM are, as a group, at increased risk for HIV, hepatitis B and certain other infections that can be transmitted by transfusion.
The policy is not unique to the United States. Many European countries have recently reexamined both the science and ethics of the lifetime MSM deferral, and have retained it. This decision is also consistent with the prevailing interpretation of the European Union Directive 2004/33/EC article 2.1 on donor deferrals.

Why doesn’t FDA allow men who have had sex with men to donate blood?

A history of male-to-male sex is associated with an increased risk for the presence of and transmission of certain infectious diseases, including HIV, the virus that causes AIDS. FDA’s policy is intended to protect all people who receive blood transfusions from an increased risk of exposure to potentially infected blood and blood products. The deferral for men who have had sex with men is based on the following considerations regarding risk of HIV:

  • Men who have had sex with men since 1977 have an HIV prevalence (the total number of cases of a disease that are present in a population at a specific point in time) 60 times higher than the general population, 800 times higher than first time blood donors and 8000 times higher than repeat blood donors (American Red Cross). Even taking into account that 75% of HIV infected men who have sex with men already know they are HIV positive and would be unlikely to donate blood, the HIV prevalence in potential donors with history of male sex with males is 200 times higher than first time blood donors and 2000 times higher than repeat blood donors.
  • Men who have had sex with men account for the largest single group of blood donors who are found HIV positive by blood donor testing.
  • Blood donor testing using current advanced technologies has greatly reduced the risk of HIV transmission but cannot yet detect all infected donors or prevent all transmission by transfusions. While today’s highly sensitive tests fail to detect less than one in a million HIV infected donors, it is important to remember that in the US there are over 20 million transfusions of blood, red cell concentrates, plasma or platelets every year. Therefore, even a failure rate of 1 in a million can be significant if there is an increased risk of undetected HIV in the blood donor population.
  • Detection of HIV infection is particularly challenging when very low levels of virus are present in the blood for example during the so-called “window period”. The “window period” is the time between being infected with HIV and the ability of an HIV test to detect HIV in an infected person.
  • FDA’s MSM policy reduces the likelihood that a person would unknowingly donate blood during the “window period” of infection. This is important because the rate of new infections in MSM is higher than in the general population and current blood donors.
  • Collection of blood from persons with an increased risk of HIV infection also presents an added risk if blood were to be accidentally given to a patient in error either before testing is completed or following a positive test. Such medical errors occur very rarely, but given that there are over 20 million transfusions every year, in the USA, they can occur. That is one more reason why FDA and other regulatory authorities work to assure that there are multiple safeguards, not just testing.
  • Several scientific models show there would be a small but definite increased risk to people who receive blood transfusions if FDA’s MSM policy were changed and that preventable transfusion transmission of HIV could occur as a result.
  • No alternate set of donor eligibility criteria (even including practice of safe sex or a low number of lifetime partners) has yet been found to reliably identify MSM who are not at increased risk for HIV or certain other transfusion transmissible infections.
  • Today, the risk of getting HIV from a transfusion or a blood product has been nearly eliminated in the United States. Improved procedures, donor screening for risk of infection and laboratory testing for evidence of HIV infection have made the United States blood supply safer than ever. While appreciative and supportive of the desire of potential blood donors to contribute to the health of others, FDA’s first obligation is to assure the safety of the blood supply and protect the health of blood recipients.
  • Men who have sex with men also have an increased risk of having other infections that can be transmitted to others by blood transfusion. For example, infection with the Hepatitis B virus is about 5-6 times more common and Hepatitis C virus infections are about 2 times more common in men who have sex with other men than in the general population. Additionally, men who have sex with men have an increased incidence and prevalence of Human Herpes Virus-8 (HHV-8). HHV-8 causes a cancer called Kaposi’s sarcoma in immunocompromised individuals.

What is self-deferral?

Self-deferral is a process in which individuals elect not to donate because they identify themselves as having characteristics that place them at potentially higher risk of carrying a transfusion transmissible disease. FDA uses self-deferral as part of a system to protect the blood supply. This system starts by informing donors about the risk of transmitting infectious diseases. Then, potential donors are asked questions about their health and certain behaviors and other factors (like travel and past transfusions) that increase their risk of infection. Screening questions help people, even those who feel well, to identify themselves as potentially at higher risk for transmitting infectious diseases. Screening questions allow individuals to self defer, rather than unknowingly donating blood that may be infected.

Is FDA’s policy of excluding MSM blood donors discriminatory?

FDA’s deferral policy is based on the documented increased risk of certain transfusion transmissible infections, such as HIV, associated with male-to-male sex and is not based on any judgment concerning the donor’s sexual orientation.

Male to male sex has been associated with an increased risk of HIV infection at least since 1977. Surveillance data from the Centers for Disease Control and Prevention indicate that men who have sex with men and would be likely to donate have a HIV prevalence that is at present over 15 fold higher than the general population, and over 2000 fold higher than current repeat blood donors (i.e., those who have been negatively screened and tested) in the USA. MSM continue to account for the largest number of people newly infected with HIV.
Men who have sex with men also have an increased risk of having other infections that can be transmitted to others by blood transfusion.

What about men who have had a low number of partners, practice safe sex, or who are currently in monogamous relationships?
Having had a low number of partners is known to decrease the risk of HIV infection. However, to date, no donor eligibility questions have been shown to reliably identify a subset of MSM (e.g., based on monogamy or safe sexual practices) who do not still have a substantially increased rate of HIV infection compared to the general population or currently accepted blood donors. In the future, improved questionnaires may be helpful to better select safe donors, but this cannot be assumed without evidence.

Are there other donors who have increased risks of HIV or other infections who, as a result, are also excluded from donating blood?
Intravenous drug abusers are excluded from giving blood because they have prevalence rates of HIV, HBV, HCV and HTLV that are much higher than the general population. People who have received transplants of animal tissue or organs are excluded from giving blood because of the still largely unknown risks of transmitting unknown or emerging pathogens harbored by the animal donors. People who have recently traveled to or lived abroad in certain countries may be excluded because they are at risk for transmitting agents such as malaria or variant Creutzfeldt-Jakob Disease (vCJD). People who have engaged in sex in return for money or drugs are also excluded because they are at increased risk for transmitting HIV and other blood-borne infections.

Why are some people, such as heterosexuals with multiple partners, allowed to donate blood despite increased risk for transmitting HIV and hepatitis?
Current scientific data from the U.S. Centers for Disease Control and Prevention (CDC) indicate that, as a group, men who have sex with other men are at a higher risk for transmitting infectious diseases or HIV than are individuals in other risk categories. While statistics indicate a rising infection rate among young heterosexual women, their overall rate of HIV infection remains much lower than in men who have sex with other men. For information on HIV-related statistics and trends, go to CDC’s HIV/AIDS Statistics and Surveillance web page.

Isn’t the HIV test accurate enough to identify all HIV positive blood donors?
HIV tests currently in use are highly accurate, but still cannot detect HIV 100% of the time. It is estimated that the HIV risk from a unit of blood has been reduced to about 1 per 2 million in the USA, almost exclusively from so called “window period” donations. The “window period” exists very early after infection, where even current HIV testing methods cannot detect all infections. During this time, a person is infected with HIV, but may not have made enough virus or developed enough antibodies to be detected by available tests. For this reason, a person could test negative, even when they are actually HIV positive and infectious. Therefore, blood donors are not only tested but are also asked questions about behaviors that increase their risk of HIV infection.

Collection of blood from persons with an increased risk of HIV infection also presents an added risk to transfusion recipients due to the possibility that blood may be accidentally given to a patient in error either before testing is completed or following a positive test. Such medical errors occur very rarely, but given that there are over 20 million transfusions every year, in the USA, they can occur. For these reasons, FDA uses a multi-layered approach to blood safety including pre-donation deferral of potential donors based on risk behaviors and then screening of the donated blood with sensitive tests for infectious agents such as HIV-1, HIV-2, HCV, HBV and HTLV-I/II.

How long has FDA had this MSM policy?
FDA’s policies on donor deferral for history of male sex with males date back to 1983, when the risk of AIDS from transfusion was first recognized. Our current policy has been in place since 1992.

FDA has modified its blood donor policy as new scientific data and more accurate tests for HIV and hepatitis became available. Today, the risk of getting HIV from a blood transfusion has been reduced to about one per two million units of blood transfused. The risk of hepatitis C is about the same as for HIV, while the risk of hepatitis B is somewhat higher.
Doesn’t the policy eliminate healthy donors at a time when more donors are needed because of blood shortages?
FDA realizes that this policy will defer many healthy donors. However, FDA’s MSM policy minimizes even the small risk of getting infectious diseases such as HIV or hepatitis through a blood transfusion.

Would FDA ever consider changing the policy?
FDA scientists continue to monitor the scientific literature and to consult with experts in CDC, NIH and other agencies. FDA will continue to publicly revisit the current deferral policy as new information becomes available.

On March 8, 2006, FDA conducted a workshop entitled “Behavior-based donor deferrals in the Nucleic Acid Test (NAT) era”. The workshop addressed scientific challenges, opportunities, and risk based donor deferral policies relevant to the protection of the blood supply from transfusion transmissible diseases, seeking input on this topic. Participants were given the opportunity to provide scientific data that could support revising FDA’s MSM deferral. The workshop provided a very active, open and broad-based scientific dialogue concerning current behavior-based deferrals and explored other options that may be considered and the data needed to evaluate them.

FDA’s primary responsibility is to enhance blood safety and protect blood recipients. Therefore FDA would change this policy only if supported by scientific data showing that a change in policy would not present a significant and preventable risk to blood recipients. Scientific evidence has not yet been provided to FDA that shows that blood donated by MSM or a subgroup of these potential donors, is as safe as blood from currently accepted donors.

FDA remains willing to consider new approaches to donor screening and testing, provided those approaches assure that blood recipients are not placed at an increased risk of HIV or other transfusion transmitted diseases.

 

References:

1. Germain, M., Remis, R.S., and Delage, G. The risks and benefits of accepting men who have had sex with men as blood donors. Transfusion 2003; 43:25-33.
2. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH; NHLBI-REDS NAT Study Group. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005, 45:254-264
3. Presentation at FDA Blood Products Advisory Committee Meeting, September 2000.
4. Soldan, K. and Sinka, K. Evaluation of the de-selection of men who have had sex with men from blood donation in England. Vox Sanguinis 2003; 84:265-273.